Masaharu Osato - Emmaus Life Director
| EMMADelisted Stock | USD 0.13 0.00 0.00% |
Director
Masaharu Osato is Director of Emmaus Life Sciences since 2019.
| Age | 63 |
| Tenure | 5 years |
| Phone | 310 214 0065 |
| Web | https://www.emmausmedical.com |
Emmaus Life Management Efficiency
The company has return on total asset (ROA) of (0.1239) % which means that it has lost $0.1239 on every $100 spent on assets. This is way below average. Emmaus Life's management efficiency ratios could be used to measure how well Emmaus Life manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 4.65 M in liabilities. Emmaus Life Sciences has a current ratio of 0.14, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Emmaus Life until it has trouble settling it off, either with new capital or with free cash flow. So, Emmaus Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Emmaus Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Emmaus to invest in growth at high rates of return. When we think about Emmaus Life's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 9 records | DIRECTOR Age | ||
| James Topper | AnaptysBio | 56 | |
| John Schmid | AnaptysBio | 55 | |
| Hollings Renton | AnaptysBio | 71 | |
| James Schoeneck | AnaptysBio | 58 | |
| Yan MBA | Adagene | 49 | |
| Nicholas Lydon | AnaptysBio | 61 | |
| Carol Gallagher | AnaptysBio | 51 | |
| Dennis Fenton | AnaptysBio | 66 | |
| Ware | AnaptysBio | 65 | |
Management Performance
| Return On Asset | -0.12 |
Emmaus Life Sciences Leadership Team
Elected by the shareholders, the Emmaus Life's board of directors comprises two types of representatives: Emmaus Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Emmaus. The board's role is to monitor Emmaus Life's management team and ensure that shareholders' interests are well served. Emmaus Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Emmaus Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
| CPA CPA, Chief Officer | ||
| Yutaka Niihara, Chairman of the Board, CEO | ||
| Lan Tran, President Chief Administrative Officer | ||
| Yasushi Nagasaki, Senior Vice President - Finance | ||
| Dale JD, G Counsel | ||
| Masaharu Osato, Director | ||
| MD MPH, Chairman CEO | ||
| Willis MS, Vice COO | ||
| Willis Lee, Vice Chairman of the Board, COO | ||
| Wei Zen, Director | ||
| Robert Dickey, Director | ||
| MS MBA, Consultant | ||
| Ian Zwicker, Director | ||
| Steven Lee, Independent Consultant | ||
| Robin Smith, Director | ||
| Joseph Sherwood, CFO | ||
| George Sekulich, VP Officer | ||
| PharmD PharmD, Clinical, Affairs |
Emmaus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Emmaus Life a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.12 | ||||
| Profit Margin | (1.14) % | ||||
| Operating Margin | (0.65) % | ||||
| Current Valuation | 49.41 M | ||||
| Shares Outstanding | 49.56 M | ||||
| Shares Owned By Insiders | 38.73 % | ||||
| Number Of Shares Shorted | 41.22 K | ||||
| Price To Earning | (1.60) X | ||||
| Price To Sales | 1.06 X | ||||
| Revenue | 20.61 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Emmaus Life in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Emmaus Life's short interest history, or implied volatility extrapolated from Emmaus Life options trading.
Pair Trading with Emmaus Life
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Emmaus Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emmaus Life will appreciate offsetting losses from the drop in the long position's value.Moving together with Emmaus OTC Stock
| 0.61 | ELOX | Eloxx Pharmaceuticals | PairCorr |
Moving against Emmaus OTC Stock
| 0.53 | JSPRW | Jasper Therapeutics | PairCorr |
| 0.52 | FBIOP | Fortress Biotech Pref Downward Rally | PairCorr |
| 0.51 | BAYRY | Bayer AG PK | PairCorr |
| 0.5 | ENGN | enGene Holdings Common | PairCorr |
| 0.5 | NGM | NGM Biopharmaceuticals Financial Report 2nd of May 2024 | PairCorr |
The ability to find closely correlated positions to Emmaus Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Emmaus Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Emmaus Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Emmaus Life Sciences to buy it.
The correlation of Emmaus Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Emmaus Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Emmaus Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Emmaus Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Emmaus OTC Stock
If you are still planning to invest in Emmaus Life Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Emmaus Life's history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |